Balancing risks: Dosing strategies for antidepressants near the end of pregnancy

Laura J. Miller, Jeffrey R. Bishop, James H. Fischer, Stacie E. Geller, Carol Macmillan

Research output: Contribution to journalShort surveypeer-review

9 Scopus citations

Abstract

There are risks inherent in failing to adequately treat major depression during pregnancy, and there are risks associated with antidepressant medication during pregnancy. Near the end of pregnancy, a partial dose taper may reduce the risk of neonatal adverse effects for women who can tolerate a brief period of subtherapeutic medication levels.

Original languageEnglish (US)
Pages (from-to)323-324
Number of pages2
JournalJournal of Clinical Psychiatry
Volume69
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint Dive into the research topics of 'Balancing risks: Dosing strategies for antidepressants near the end of pregnancy'. Together they form a unique fingerprint.

Cite this